ASTRAZENECA - United Kingdom 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:> 1000
Total Number of Projects:500-600
2019
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:600-700
Total Number of Projects:100-200

Ranking timeline:

Project Participation Performance(2019-01-01 - 2021-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 31
As coordinator: 0
As participant: 31
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 32.955.948 2.132.079 8
2020 0 38.904.431 1.086.449 7
2019 0 170.536.767 3.310.038 16

Networking:

Partners:

Institution:Projects [No]:
BAYER11
NOVARTIS PHARMA11
JANSSEN PHARMACEUTICA NV10
PFIZER LIMITED9
SANOFIAVENTIS8
F HOFFMANNLA ROCHE7
KAROLINSKA INSTITUTE7
KATHOLIEKE UNIVERSITEIT LEUVEN7
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG5
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT5
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN5
UCB BIOPHARMA5
UNIVERSITAIR MEDISCH CENTRUM UTRECHT5
ELI LILLY AND COMPANY LIMITED4
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE4
STICHTING LYGATURE4
TAKEDA DEVELOPMENT CENTRE EUROPE4
TAKEDA PHARMACEUTICALS INTERNATIONAL4
TEVA PHARMACEUTICAL INDUSTRIES LIMITED4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD4
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN4
THE UNIVERSITY OF MANCHESTER4
UNIVERSITAET ZUERICH4
UNIVERSITY COLLEGE LONDON4
ABBVIE INC3
ACADEMIC MEDICAL CENTRE AMSTERDAM3
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
FORUM DES PATIENTS EUROPEENS3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
KING'S COLLEGE LONDON3
LEIDEN UNIVERSITY3
LEIDS UNIVERSITAIR MEDISCH CENTRUM3
MERCK SHARP & DOHME CORP3
UNIVERSITEIT UTRECHT3
UNIVERSITY OF CAMBRIDGE3
UNIVERSITY OF COPENHAGEN3
UNIVERSITY OF GLASGOW3
UNIVERSITY OF NEWCASTLE UPON TYNE3
UPPSALA UNIVERSITET3
ACADEMISCH ZIEKENHUIS GRONINGEN2
ALLERGAN LIMITED2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL2
CLINIQUES UNIVERSITAIRES SAINTLUC2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
DREEM2
DRESDEN UNIVERSITY OF TECHNOLOGY2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE2
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG2
GRUNENTHAL2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
HELSE STAVANGER HF2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS2
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES2
IXSCIENT LIMITED2
MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
MCROBERTS BV2
MEDIZINISCHE UNIVERSITAET WIEN2
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS2
NORGES TEKNISKNATURVITENSKAPELIGE UNIVERSITET NTNU2
NOVO NORDISK2
PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
RISE RESEARCH INSTITUTES OF SWEDEN AB2
SERVICIO MADRILENO DE SALUD2
STICHTING MLC FOUNDATION2
STICHTING VUMC2
SYDDANSK UNIVERSITET2
TEAM IT RESEARCH SL2
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA2
THE UNIVERSITY OF EXETER2
UNIVERSIDAD POLITECNICA DE MADRID2
UNIVERSITA VITASALUTE SAN RAFFAELE2
UNIVERSITAT WIEN2
UNIVERSITATSKLINIKUM ERLANGEN2
UNIVERSITE DU LUXEMBOURG2
UNIVERSITEIT GENT2
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK2
UNIVERSITY COLLEGE DUBLIN2
UNIVERSITY OF DUNDEE2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF OSLO2
UNIVERSITY OF SOUTHAMPTON2
A PERSIDIS & SIA OE1
ABO AKADEMI1
ACCADEMIA EUROPEA PER LA RICERCA APPLICATA ED IL PERFEZIONAMENTO PROFESSIONALE BOLZANO1
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS1
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN1
AGILENT TECHNOLOGIES FRANCE1
AKERSHUS UNIVERSITETSSYKEHUS HF1
ALACRIS THERANOSTICS1
ALCEDIAG1
AMGEN LIMITED1

Constancy:

Total number of partners: 583
Partner loyalty:
Frequent Partner: (> 2 projects): 191
Rare Partner: 392
Frequent / Rare Partner Ratio: 0.49

Project overview:

Start dateProjectacronymrolefundingpartners
2021-07-01Building a reproducible single-cell experimental workflow to capture tumour drug persistence PERSIST-SEQparticipant7.057.98014
2021-07-01Real World Handling of Protein Drugs - Exploration, Evaluation and Education RealHOPEparticipant3.139.98425
2021-05-01ENable LIGHT- and synthetic biology-driven volumetric bioprinting of functional human tissues ENLIGHTparticipant3.594.9258
2021-01-01Boosting advanced doctoral training in innovative colon targeting drugs COLOTANparticipant3.533.10810
2021-01-01EU Training Network in understanding the molecular regulation and the role of endo-lysosomal processes in cardio-metabolic diseases EndoConnectparticipant4.074.58912
2021-01-01Oligonucleotides for Medical Applications OLIGOMEDparticipant4.153.34412
2021-01-01Advanced machine learning for Innovative Drug Discovery AIDDparticipant3.926.61515
2021-01-01A fully integrated, animal-free, end-to-end modelling approach to oral drug product development InPharmaparticipant3.475.40211
2020-11-01Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment Gravitate-Healthparticipant9.280.00040
2020-09-01NExt ApplicationS of Quantum Computing NEASQCparticipant4.671.33312
2020-09-01Prioritisation and Risk Evaluation of Medicines in the EnviRonment PREMIERparticipant4.550.00025
2020-07-01C-H Activation for Industrial Renewal CHAIRparticipant3.938.27014
2020-02-01Cooperation towards a sustainable chemical industry CO2PERATEparticipant4.156.28710
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69429
2020-01-01Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery TrainCKDisparticipant4.017.84810
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95337
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52347
2019-10-01PancREatic Cancer OrganoiDs rEsearch Network PRECODEparticipant3.992.89215
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99833
2019-09-01EXpanding Platforms for Efficacious mRNA Therapeutics EXPERTparticipant14.931.33811
2019-06-01MachinE Learning Ledger Orchestration for Drug DiscoverY MELLODDYparticipant8.000.00017
2019-05-01Saracatinib Trial tO Prevent FOP STOPFOPparticipant999.7106
2019-05-01Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug PD-MINDparticipant999.69810
2019-05-01INnate-ImmunomeTabolIsm as Antiviral TargEt INITIATEparticipant4.054.10614
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89735
2019-03-01A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies V.A. Cureparticipant3.792.13617
2019-03-01Neurotoxicity De-Risking in Preclinical Drug Discovery NeuroDeRiskparticipant5.331.00018
2019-01-01FAIRplus FAIRplusparticipant3.996.15022
2019-01-01Stirling heat pump for high temperature industrial use Highliftparticipant2.439.5123
2019-01-01A European Training Network to Combat Bone Pain BonePainIIparticipant4.291.66512

Alias institution names:

  • ASTRAZENECA